Corindus Vascular Robotics (NYSEMKT:CVRS) -0.88% announced that Aquilla "Quill" Turk, D.O. has joined as Chief Medical Officer, Neuroendovascular.
Dr. Turk is a practicing physician at the Medical University of South Carolina where he serves as Director of the Stroke and Cerebrovascular Program, Director of the Neuroendovascular Program, and Professor with a joint appointment in the Departments of Radiology and Neurosurgery.
Dr. Turk will serve alongside Dr. Aaron Grantham, Corindus’ Cardiovascular CMO, to spearhead the company’s clinical initiatives and expand robotic treatment into neurovascular procedures, specifically targeting acute ischemic stroke.
Subscribe for full text news in your inbox